Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study
Eroglu TE, Coronel R, Souverein PC
Eur Heart J Cardiovasc Pharmacother. 2024;pvae022.
Leggi
Eroglu TE, Coronel R, Souverein PC
Eur Heart J Cardiovasc Pharmacother. 2024;pvae022.
Leggi
21/03/2024
Leggi
21/03/2024
Leggi
21/03/2024
Leggi
Rivera FB, Lumbang GNO, Gaid DRM, et al.
Diabetes Obes Metab. Pub. online 20 Mar 2024.
Leggi
Garg SK, Akturk HK, Kaur G, et al.
Diabetes Technol Ther. Pub. online 21 Mar 2024.
Leggi
Zhou BG, Xia JL, Jiang X, et al.
BMC Endocr Disord. 2024;24(1):40.
Leggi
Martine-Edith G, Zaremba N, Divilly P, et al.
Diabetes Technol Ther. Pub. online 21 Mar 2024.
Leggi
Lee CG, Ciarleglio A, Edelstein SL, et al.
Diabetes Care. 2024;dc232009.
Leggi
Bell DSH, Jerkins T
Diabetes Obes Metab. Pub. online 22 Mar 2024.
Leggi